Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Evaluation of Two Second-Line Therapeutic Approaches for Immune Thrombocytopenia (ITP) - a Pragmatic Randomized Controlled Trial

NCT07051915 is registered in ClinicalTrials.gov with Ostfold Hospital Trust as lead sponsor.

NCT NCT07051915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07051915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Evaluation of Two Second-Line Therapeutic Approaches for Immune Thrombocytopenia (ITP) - a Pragmatic Randomized Controlled Trial
Lead sponsor
Ostfold Hospital Trust
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 15, 2025
Completion date
December 31, 2029
Enrollment
220 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

thrombocytopenia purpura